A Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Yusuf Yazici, M.D.
Biosplice Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
74 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Anniston, Alabama, United States
- Research Site
Birmingham, Alabama, United States
- Research Site
Mobile, Alabama, United States
- Research Site
Chandler, Arizona, United States
- Research Site
Phoenix, Arizona, United States
- Research Site
Phoenix, Arizona, United States
- Research Site
Tucson, Arizona, United States
- Research Site
Anaheim, California, United States
- Research Site
Canoga Park, California, United States
- Research Site
Carmichael, California, United States
- Research Site
Cerritos, California, United States
- Research Site
El Cajon, California, United States
- Research Site
Gold River, California, United States
- Research Site
La Mesa, California, United States
- Research Site
Los Angeles, California, United States
- Research Site
Rancho Mirage, California, United States
- Research Site
Sacramento, California, United States
- Research Site
San Diego, California, United States
- Research Site
San Marcos, California, United States
- Research Site
Spring Valley, California, United States
- Research Site
Boulder, Colorado, United States
- Research Site
Stamford, Connecticut, United States
- Research Site
Trumbull, Connecticut, United States
- Research Site
Waterbury, Connecticut, United States
- Research Site
Clearwater, Florida, United States
- Research Site
Coral Gables, Florida, United States
- Research Site
DeLand, Florida, United States
- Research Site
Edgewater, Florida, United States
- Research Site
Lauderdale Lakes, Florida, United States
- Research Site
Miami, Florida, United States
- Research Site
Pinellas Park, Florida, United States
- Research Site
Marietta, Georgia, United States
- Research Site
Woodstock, Georgia, United States
- Research Site
Chicago, Illinois, United States
- Research Site
Evansville, Indiana, United States
- Research Site
Newton, Kansas, United States
- Research Site
Prairie Village, Kansas, United States
- Research Site
Wichita, Kansas, United States
- Research Site
Lexington, Kentucky, United States
- Research Site
Jefferson, Louisiana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Apr 2017
- Primary completion
- 30 Apr 2018
- Completion
- 30 Apr 2018
- Last update posted
- 11 Jun 2021
- Registered enrollment
- 700
- Registry id
- NCT03122860
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.